PRODUCT MONOGRAPH. Pr. JEVTANA. ®. Cabazitaxel for injection. Concentrated Solution 40 mg/mL. (60 mg/ mL). Antineoplastic Agent. JEVTANA in combination with prednisone or prednisolone is indicated for the The printed package leaflet of the medicinal product must state the name and. Package leaflet: Information for the patient. JEVTANA® 60 mg concentrate and solvent for solution for infusion. cabazitaxel. Read all of this leaflet carefully.

Author: Sadal Mik
Country: Iceland
Language: English (Spanish)
Genre: Politics
Published (Last): 10 November 2012
Pages: 176
PDF File Size: 9.4 Mb
ePub File Size: 7.41 Mb
ISBN: 148-1-61406-806-5
Downloads: 8997
Price: Free* [*Free Regsitration Required]
Uploader: Arashigami

Healthcare Professionals Only Sanofi Genzyme. Dosing and Dose Modifications.

Dosing and Dose Modifications

Low white blood cells, which can cause you to get serious infections, and may lead to death. For more information, ask your HCP or pharmacist. Healthcare Professionals I am a U.

JEVTANA is contraindicated in patients who have a history of severe hypersensitivity reactions to cabazitaxel or to other drugs formulated with polysorbate Adverse Reactions Hematologic Lab Abnormalities.

Cabazitaxel (Jevtana)

Secondary prophylaxis with G-CSF should be considered in all patients at increased risk for neutropenia complications. To email a medicine you must sign up and log in. Cabazzitaxel active substance is cabazitaxel. It is written for patients and gives information about taking or using a medicine.


Dosing and Dose Modifications for JEVTANA® (cabazitaxel) Injection

This may affect your ability to father a child. Below cabxzitaxel a text only representation of the Patient Information Leaflet. You may need to go to the hospital for treatment. Patients should receive premedication. Febrile neutropenia or neutropenic infection.

One ml of concentrate contains 40 mg cabazitaxel. Pregnancy, breast-feeding and fertility JEVTANA should not be used in pregnant women or women of childbearing age not using contraception. Sanofi Patient Inert Resources.

One single use clear glass vial, closed with a grey chlorobutyl rubber closure sealed by an aluminium cap with a light green plastic flip-off cover containing 1.

See a doctor immediately if you notice any of the following side effects:. Obtain frequent blood counts to monitor for neutropenia. You may need to read it again. Packqge your HCP if you have blood in your urine, burning sensation during urination, or frequent or urgent need to urinate.

Men who are 65 years or older may be more likely to have Show Cabazitadel. Tell your HCP right away if you develop any new or worsening symptoms, including: One single use clear glass vial, closed with a grey chlorobutyl rubber closure sealed by a gold colour aluminium cap with a colourless plastic flip-off cover, containing 4. Tell your HCP ibsert If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

  FD X 50-190 PDF

Your doctor will calculate your body surface area in square meters m 2 and will decide the dose you should have. If any of the above applies to you, tell your doctor immediately.

Tell your HCP if you develop these signs or symptoms: You are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because JEVTANA may pafkage male fertility. Ask your doctor to give you information about this other medicine.

What is a Patient Information Leaflet and why is it useful?